The 2012 AHS/AAN guidelines for prevention of episodic migraine: a summary and comparison with other recent clinical practice guidelines (Q34279280)

1 August 2017

title

The 2012 AHS/AAN guidelines for prevention of episodic migraine: a summary and comparison with other recent clinical practice guidelines (English)

1 reference

1 August 2017

1 reference

Elizabeth Loder

1 reference

1 August 2017

Rebecca Burch

series ordinal

1 reference

1 August 2017

Paul Rizzoli

series ordinal

1 reference

1 August 2017

publication date

1 June 2012

1 reference

1 August 2017

1 reference

1 August 2017

1 reference

1 August 2017

1 reference

1 August 2017

page(s)

930-945

1 reference

Evidence-based guideline update: NSAIDs and other complementary treatments for episodic migraine prevention in adults: report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society

1 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2012.02185.X

Evidence-based guideline update: pharmacologic treatment for episodic migraine prevention in adults: report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2012.02185.X

Cost-effectiveness of topiramate in migraine prevention: results from a pharmacoeconomic model of topiramate treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2012.02185.X

Migraine prevalence, disease burden, and the need for preventive therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2012.02185.X

What should clinicians do when faced with conflicting recommendations?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2012.02185.X

Patient and practitioner noncompliance: rationing, therapeutic uncertainty, and the missing conversation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2012.02185.X

Quality varies across clinical practice guidelines for mammography screening in women aged 40–49 years as assessed by AGREE and AMSTAR instruments

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2012.02185.X

An independent AGREE evaluation of the Occupational Medicine Practice Guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2012.02185.X

The quality of clinical practice guidelines over the last two decades: a systematic review of guideline appraisal studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2012.02185.X

Practice parameter: evidence-based guidelines for migraine headache (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2012.02185.X

Outcome reporting in industry-sponsored trials of gabapentin for off-label use

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2012.02185.X

Guidelines on the diagnosis and the current management of headache and related disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2012.02185.X

EFNS guideline on the drug treatment of migraine--revised report of an EFNS task force

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2012.02185.X

Evaluation and registration of adverse events in clinical drug trials in migraine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2012.02185.X

Adverse events in randomized trials: neglected, restricted, distorted, and silenced.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2012.02185.X

Menstrual migraine: timing is everything

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2012.02185.X

Out of sight but not out of mind: how to search for unpublished clinical trial evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2012.02185.X

Impact of document type on reporting quality of clinical drug trials: a comparison of registry reports, clinical study reports, and journal publications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2012.02185.X

Understanding why evidence from randomised clinical trials may not be retrieved from Medline: comparison of indexed and non-indexed records

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2012.02185.X

Missing clinical trial data

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2012.02185.X

Subcutaneous sumatriptan: results of a peculiar, unpublished, comparative, double-blind, randomised, and controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2012.02185.X

Published and not fully published double-blind, randomised, controlled trials with oral naratriptan in the treatment of migraine: a review based on the GSK Trial Register

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2012.02185.X

Unpublished clinical trials with sumatriptan

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2012.02185.X

Effect of reporting bias on meta-analyses of drug trials: reanalysis of meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2012.02185.X

AGREE II: Advancing guideline development, reporting and evaluation in health care

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4610.2012.02185.X

10.1111/J.1526-4610.2012.02185.X

21 January 2018

Identifiers

DOI

1 reference

1 August 2017

1 reference